Indian Journal of Obstetrics and Gynecology Research

Print ISSN: 2394-2746

Online ISSN: 2394-2754

CODEN : IJOGCS

Indian Journal of Obstetrics and Gynecology Research (IJOGR) open access, peer-reviewed quarterly journal publishing since 2014 and is published under auspices of the Innovative Education and Scientific Research Foundation (IESRF), aim to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. IESRF is dedicated to the transfer of technology and research by publishing scientific journals, research content, providing professional’s membership, and conducting conferences, seminars, and award more...

  • Article highlights
  • Article tables
  • Article images

Article statistics

Viewed: 473

PDF Downloaded: 264


Get Permission Nayak: Significance of red cell alloantibodies other than anti-D during pregnancy and their effect on the newborn: A case series


Introduction

Alloantibodies against non-self red cell antigens are triggered most frequently by sensitizing events like transfusion, transplantation and pregnancy.1, 2 Such alloantibodies, also called irregular antibodies not only cause difficulty in finding suitable blood for the patient but also threaten the fetus if it develops or recurs during pregnancy. A recent review article by Gupta et al., reiterates the significance of non-ABO red cell antibodies occurring in pregnancies.3 Infact, occurrence of more persistent alloantibodies in females has been observed to be predominantly due to pregnancies.4

Western literature shows 1 in every 80 pregnant female have alloantibodies which affects every 1 in 300 to 600 live births.5, 6, 7 Developed countries have well-established guidelines for screening for red cell alloantibodies in pregnancy.8, 9, 10 Policies on alloantibody related safety during pregnancy and awareness about it has been lacking in our country beyond anti-D. Red cell antigens other than D like C, c, E, e, Kell, M, N and sometimes Duffy antigens are immunogenic.11 Antibodies formed against these antigens during pregnancy can be harmful for fetus and cause hemolytic disease of fetus and newborn (HDFN) if not intervened. The problem potentially lingers in the newborn adding to morbidity. Investigation of indirect Coombs test (ICT) better known as indirect antiglobulin test (IAT) which looks for alloantibodies in patient’s plasma is most often limited to Rh D negative patients. Thus, alloantibodies occurring in Rh D positive pregnant patients are most often missed.

As per pre-transfusion protocols, ABO blood group and screening for alloantibodies in all patients is essential.1, 2 In IAT patients’ plasma is screened against commercially available phenotyped red cells to ascertain if any alloantibody is present. The implicated alloantibody is identified by an array of investigations which includes but may not limit to IAT of patient plasma against another extended set of phenotyped red cells. Complex immunohematology (IH) procedures like enzyme treatment of cells, adsorption-elution, polyethylene glycol treatment, etc could be added to identify the single or multiple alloantibodies occurring together in some patients.12 Some interesting cases of alloantibodies other than anti-D occurring during antenatal or postnatal period, most of which were detected incidentally are presented in this case series.

Materials and Methods

Study was done in tertiary care hospital in North India during 2019-2020. IAT was performed as a routine test for compatibility. It was performed on anti-IgG + anti-C3d antihuman globulin embedded gel cards which are columns containing either gel (Bio-Rad) by column agglutination technique (ID Dia cell I-II-III; Bio-Rad, DiaMed GmbH, Switzerland) or solid phase red cell adherence (SPRCA) technique (Immucor, Inc. Norcross, GA) on an automated platform Echo (Immucor, INC Norcross, GA, USA). Cases which were detected to have IAT positive were evaluated for the irregular antibody by use of gel cards technique using identification panel red cells ID-DiaPanel (Bio-Rad DiaMed GmbH, Switzerland)

Cases Report

The eight cases which are mentioned in table I are as follows:

Case I

A booked case of term pregnancy was admitted for planned caesarean section. One unit of packed red blood cell (PRBC) was arranged by the obstetrician. The IAT was found positive. Specificity of the alloantibody was anti-E. The patient was phenotyped for the Rh and Kell antigens and was ‘E’ negative. One unit of E antigen negative packed red blood cell (PRBC) compatible on antihuman globulin (AHG) phase was used for transfusion. Transfusion was uneventful for the mother. The newborn had DAT positive (2+) and raised indirect bilirubin by day 3 of life. However, the baby recovered well with phototherapy.

Case II

A 26 years old female came for follow-up of still birth at term pregnancy which terminated three months back. She had received no transfusions ever. She had one child delivered six years back and no abortions. PRBC was arranged in lieu of low hemoglobin. Her IAT was positive and she was found to be carrying two alloantibodies, anti-E and anti-c in her plasma. Her red cells phenotyped ‘E’ and ‘c’ negative. Possibility of hemolytic disease of fetus and newborn (HDFN) in the recently delivered fetus could not be ruled out.

Case III

A 39-year old female patient was admitted for caesarean section with simultaneous fibroid resection was found to have alloantibody anti-Fya during her pre-transfusion investigation. She had received blood transfusion 4-5 years back following hemorroidectomy. She had an abortion 1-2 years back at a gestational age of 6-8 weeks. In the current pregnancy, the baby delivered was DAT positive. The Fya antigen status of the baby could not be investigated due to the fact that the red cells were already sensitized thus IAT test for antigen typing of Duffy was not possible serologically. Elution study was missed. The newborn did not require any transfusion and recovered with medical management only. Finding Fya antigen negative PRBC was a challenge and required multiple unit crossmatch and typing.

Case IV

A 19-year old pregnant patient was under follow-up at our hospital. She had an abortion 7 to 8 months prior to her current pregnancy. She received red cell transfusion shortly after the abortion. She was Rh D negative and she had not received any RhIg immunoglobulin in the ongoing pregnancy. The IAT was being seeked to decide the administration of Rh immunoprophylaxis. The IAT tested positive and anti-E alloantibody was detected. Since the pregnancy was continuing, the alloantibody titer estimation was important. The titer of allo anti-E antibody was below detectable limit by the standard tube technique. Ultrasonographic findings of the fetus were within normal limits. The next follow-up was done after 4 weeks which had similar findings. The pregnancy continued till term with an unaffected fetus. DAT of the newborn could not be performed.

Case V

A case of a postnatal lady, who delivered a still born baby at 28 weeks gestation was referred to TM department to look for alloantibodies in patient’s plasma, if any. She had one abortion and two live births. She had received PRBC transfusions after second delivery. The current day investigations revealed she had multiple alloantibodies, anti-E and anti-K none of which were diagnosed earlier. Baby’s sample was not available for evaluation.

Case VI

The TM department received request for blood arrangement of a newborn baby who had increasing trends of bilirubin. Pediatrician wanted to stay prepared for an exchange transfusion, in case it is required. On investigation, the baby was found to be DAT positive (2+). As a protocol, mother’s blood sample was received for crossmatch. She had an abortion in the 1st pregnancy and this baby was her 1st live child. Her investigations showed IAT positive and the alloantibody identified was anti-E. The baby was typed for ‘E’ antigen by IgM type of antisera and was found to be ‘E’ antigen positive. An elution study of baby’s red cells was missed. The baby however, did not require exchange transfusion and improved with phototherapy and medical management.

Case VII

A lady in her third term pregnancy was admitted for delivery. She also had received blood transfusion during her previous deliveries. She was found to be IAT positive. The further investigation found her to be having two alloantibodies i.e anti-c and anti-E. However, the fetus was healthy. The baby delivered did not require any intervention.

Case VIII

A lady with bad obstetrics outcomes in two subsequent pregnancies was referred for IAT test to TM department. She had never received any blood transfusion nor had any abortion. On further work-up, the implicated alloantibody found was anti-M. The DAT of the still born 2nd baby was found to be 2+ positive. The still born child appeared to have hydrops clinically as per the obstetrician. Elution studies were done on the baby’s sample. Anti-M antibody could be eluted, thereby adding strength to the diagnosis of HDFN.

Discussion and Conclusion

The case series attempts to draw readers’ attention towards potentially problematic alloantibodies which interfere in ante and postnatal periods irrespective of the Rh D status of patient. Every Rh D positive patient solicits as much attention on her IAT status as of an Rh D negative case, as highlighted in this case series. Alloantibodies reported here belong to Rh, Kell, Duffy and MNS blood group systems. Most were incidentally detected during pre-transfusion testing done at the time of delivery whereas one of the non anti-D alloantibody was detected during routine IAT of a Rh D negative antenatal case, as a usual practice. Interestingly, three cases (II, V and VII) had multiple alloantibodies. The fetal red cells were affected as confirmed by DAT of newborn in four cases. In two cases, the fetuses escaped HDFN which could possibly be because the fetus did not inherit corresponding antigen on their red cells. Two mothers presented late after still birth, during follow up for transfusions thus samples of baby could not be evaluated. Blood transfusion is arranged for many institutional deliveries in our country whether blood is utilized or not. The same set of investigations i.e IAT and alloantibody identification (if IAT is positive) are essential to provide safe PRBC for the mother. Then why should the IAT be restricted to Rh D negative cases or high risk pregnancies? The true incidence of alloantibody in pregnancy in India is still elusive as it stays uninvestigated in majority of pregnancies.

Several other studies conducted in India corroborate to findings in this case series and have seen alloantibodies against Rh, Kell, Kidd, MNS, Lewis blood group system in antenatal and postnatal cases.13, 14, 15, 16 Some studies recommend routine antibody screen in all antenatal cases.17, 18 However, some other studies by Gothwal et al. and Suresh et al. suggest that routine antibody screen should restrict to patients with bad obstetric history.19, 20 Though the screening done on a pregnant patient at first visit is a matter of debate in the country, the test done at 28 weeks or thereafter should not be of much argument as the same IAT test is essential component of compatibility test for red cell transfusions. PRBC transfusion is not an uncommon practice in obstetrics.21

Majority of the patients reported here had anti-E alloantibody. Finding antigen ‘E’ negative, ‘K’ negative red cell units for such patients is not tough as the incidence of ‘E’ antigen is nearly 20% and ‘K’ antigen is around 2% in blood donors.22, 23, 24 However, incidence of ‘Fya’ negative donors and ‘M’ negative donors is relatively less i.e around 12-40% and 12-24% respectively.23, 24 Finding appropriate red cell units in such circumstances takes time and efforts. Anti-K antibodies affect the erythropoiesis process as Kell antigen is expressed not only on mature red cells but also in the precursor red cell thereby making the anemia of fetus more pronounced.1, 2 Though the mechanism of red cell destruction due to anti-M antibodies is not exactly known, studies have seen fetal anemia due to red cell destruction as well as suppression of precursor cells.25 Two of the patients reported here had anti-K and anti-M. Both patients had still born babies. Features of hydrops were clear in the still born baby of case VIII who had anti-M. However, such history was missed from the other patient.

Alloantibody titer estimation is done against appropriate cells and should ideally be repeated every fortnight till 28th week of gestation and every weekly thereafter.9 It is often correlated with the fetal middle cerebral artery (MCA) flow Doppler. The critical titer level is defined at around 16 to 32 for anti-D antibody which is the most common alloantibody found in pregnancy.26 For all other alloantibodies, an increase in two fold titer levels estimated sequentially warrants attention.9 Koelewijn et al, described various alloantibodies in pregnancies including those that were seen in cases reported here.27 They also researched the clinically significant titers of various alloantibodies. They found that critical titer of 16 stands good for majority of alloantibodies. Since all the alloantibodies reported here were detected only at the time of delivery, titration was not indicated. The anti-E antibody which was detected in the Rh D negative patient i.e case IV had anti-E titer not detectable by conventional tube technique at anti-IgG plus anti-C3d antihuman globulin phase.

In India, guidelines for screening the pregnant patients of Rh D negative status is in place, however clarity for Rh D positive females is lacking. Larger studies are needed to ascertain the true incidence of alloimmunization in preganancy. Advanced IH investigations essential for correct treatment in alloimmunized patients are limited to TM centers of tertiary care hospitals. In a resource limited country like India where majority of the blood centres lack such facilities, the best practice would be timely identification of positive case of IAT and referral to hospitals with expert obstetricians, fetal medicine experts and TM specialists to provide optimum care to the pregnant female, the fetus and stay prepared for the newborn.

Source of Funding

None.

Conflict of Interest

Author disclose that there is no conflict of interest.

References

1 

MB Veenhof JJMV Roosmalen A Brand TL Simon J McCullough EL Snyder BG Solheim RG Strauss Obstetric transfusion practicePrinciples of transfusion medicine5th EdWiley-BlackwellOxford201650734

2 

JR Storry Mk Fung BJ Grossman CD Hillyer CM Westhoff Other Blood Group Systems and AntigensTechnical ManualAmerican Association of Blood BanksBethesda, MD201433763

3 

GK Gupta R Balbuena-Merle JE Hendrickson CA Tormey Immunohematologic aspects of alloimmunization and alloantibody detection: A focus on pregnancy and hemolytic disease of the fetus and newbornTransfus Apher Sci2020595102946

4 

JS Castleman MD Kilby Red cell alloimmunization: A 2020 updatePrenat Diagn202040910991108

5 

HM Smith RS Shirey SK Thoman JB Jackson Prevalence of clinically significant red blood cell alloantibodies in pregnant women at a large tertiary-care facilityImmunohematology201329412730

6 

KB Markham KQ Rossi HN Nagaraja O Shaughnessy RW O'Shaughnessy Hemolytic disease of the fetus and newborn due to multiple maternal antibodiesAm J Obstet Gynecol20152131618

7 

JM Koelewijn TG Vrijkotte CEVD Schoot GJ Bonsel M DeHaas Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the NetherlandsTransfusion200848594152

8 

C Milkins J Berryman C Cantwell C Elliott R Haggas J Jones Guidelines for pre-transfusion compatibility procedures in blood transfusion laboratories. British Committee for Standards in HaematologyTransfus Med2012231335

9 

The Management of Women with Red Cell Antibodies During Pregnancy. (Green-Top Guidelines no. 65) 2014https://shorturl.at/psKP4

10 

Patient Blood Management Guidelines: Module 5 – Obstetrics and Maternity2015National Blood AuthorityCanberra, Australiahttps://ranzcog.edu.au/wp-content/uploads/2022/05/Patient-Blood-Management-Guidelines-Module-5-obstetrics-and-maternity.pdf

11 

J White H Qureshi E Massey M Needs G Byrne G Daniels British Committee for Standards in Haematology. Guideline for blood grouping and red cell antibody testing in pregnancyTransfus Med201626424663

12 

PS Walker JR Hamilton MK Fung BJ Grossman CD Hillyer CM Westhoff Other Blood group systems and antigensTechnical manualAmerican Association of Blood BanksBethesda2014391424

13 

M Sidhu R Bala N Akhtar V Sawhney Prevalence, Specificity and Titration of Red Cell Alloantibodies in Multiparous Antenatal Females at a Tertiary Care Centre from North IndiaIndian J Hematol Blood Transfus201632330711

14 

J Varghese MP Chacko M Rajaiah D Daniel Red cell alloimmunization among antenatal women attending a tertiary care hospital in south IndiaIndian J Med Res201313816871

15 

S Pahuja SK Gupta M Pujani M Jain The prevalence of irregular erythrocyte antibodies among antenatal women in DelhiBlood Transfus20119438893

16 

S Basu R Kaur G Kaur Hemolytic disease of the fetus and newborn: Current trends and perspectivesAsian J Transfus Sci20115137

17 

J Patel R Shukla S Gupte Red cell alloimmunization in multitransfused patients and multiparous womenIndian J Hematol Blood Transfus20092524952

18 

SK Dholakiya S Bharadva JH Vachhani BS Upadhyay Red cell alloimmunization among antenatal women attending tertiary care centerAsian J Transfus Sci2021151526

19 

M Gothwal P Singh A Bajpai N Garg G Yadav C Sharma Red cell alloimmunization in pregnancy: a study from a premier tertiary care centre of Western IndiaObstet Gynecol Sci20226628493

20 

B Suresh KVS Babu R Arun DS Jothibai T Bharathi Prevalence of “unexpected antibodies” in the antenatal women attending the Government maternity hospital, TirupatiJ Clin Sci Res2015412230

21 

D Kandasamy AK Selvarajan JD Jeyakumar Outcome of audit and education on blood transfusion practice in obstetrics settingHematol Transfus Cell Ther20224421515

22 

MA Kahar RD Patel Phenotype frequencies of blood group systems (Rh, Kell, Kidd, Duffy, MNS, P, Lewis, and Lutheran) in blood donors of south Gujarat, IndiaAsian J Transfus Sci201481515

23 

B Thakral K Saluja RR Sharma N Marwaha Phenotype frequencies of blood groups systems (Rh, Kell, Kidd, Duffy, MNS, P, Lewis, and Lutheran) in north Indian blood donorsTransfus Apher Sci2010431722

24 

RN Makroo A Bhatia R Gupta J Phillip Prevalence of Rh, Duffy, Kell, Kidd & MNSs blood group antigens in the Indian blood donor populationIndian J Med Res201313735216

25 

H Yasuda H Ohto KE Nollet K Kawabata S Saito Y Yagi Hemolytic disease of the fetus and newborn with late-onset anemia due to anti-M: a case report and review of the Japanese literatureTransfus Med Rev201428116

26 

RD Mcbain CA Crowther P Middleton Anti-D administration in pregnancy for preventing Rhesus alloimmunisationCochrane Database Syst Rev201520159CD000020

27 

JM Koelewijn YM Slootweg C Folman ILV Kamp D Oepkes MD Haas Diagnostic value of laboratory monitoring to predict severe hemolytic disease of the fetus and newborn in non-D and non-K-alloimmunized pregnanciesTransfusion20206023919



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Article type

Case Series


Article page

525-529


Authors Details

Sweta Nayak*


Article History

Received : 16-07-2023

Accepted : 23-10-2023


Article Metrics


View Article As

 


Downlaod Files